News

Healio26m
Tirzepatide bests semaglutide for weight loss in adults with obesity
Tirzepatide conferred significantly greater weight loss than semaglutide at 72 weeks for adults with overweight or obesity, ...
TCTMD18h
Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5
Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.
New Atlas10h
Dual-target weight-loss drug is 47% more effective than its rival
The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published ...
MedPage Today on MSN18h
Zepbound and Wegovy Go Head to Head for Obesity: And the Winner Is ...
Tirzepatide (Zepbound) came out on top against semaglutide (Wegovy) for treating obesity in the head-to-head SURMOUNT-5 trial ...
Applied Clinical Trials Online23h
Tirzepatide Demonstrates Superior Weight Loss to Semaglutide in 72-Week Phase IIIb SURMOUNT-5 Trial
In the first head-to-head comparison of leading incretin-based therapies, Eli Lilly’s dual GIP/GLP-1 receptor agonist ...
This Drug Is Nearly 50 Percent More Effective Than Wegovy
A new study found users of one drug lost almost 50 percent more weight that users of Wegovy. People taking Eli Lilly’s ...
Explore more
Tampa Free Press1h
FDA Warns Against Unapproved, Compounded GLP-1 Weight Loss Drugs
The U.S. Food and Drug Administration (FDA) has issued a warning to patients and healthcare professionals regarding the use ...
Newser on MSN16h
Mounjaro Beats Ozempic in Head-to-Head Study
Mounjaro wins bragging rights over Ozempic in a new weight-loss study—though it's one that was funded by the maker of ...